http://rdf.ncbi.nlm.nih.gov/pubchem/reference/19340316

Outgoing Links

Predicate Object
contentType Journal Article|Research Support, Non-U.S. Gov't
endingPage 1042
issn 0022-3565
1521-0103
issueIdentifier 3
pageRange 1034-1042
publicationName The Journal of pharmacology and experimental therapeutics
startingPage 1034
bibliographicCitation Bardin L, Assié M, Pélissou M, Royer-Urios I, Newman-Tancredi A, Ribet J, Sautel F, Koek W, Colpaert FC. Dual, Hyperalgesic, and Analgesic Effects of the High-Efficacy 5-Hydroxytryptamine 1A (5-HT1A) Agonist F 13640 [(3-Chloro-4-fluoro-phenyl)-[4-fluoro-4-{[(5-methyl-pyridin-2-ylmethyl)-amino]-methyl}piperidin-1-yl]methanone, Fumaric Acid Salt]: Relationship with 5-HT1A Receptor Occupancy and Kinetic Parameters. J Pharmacol Exp Ther. 2004 Nov 04;312(3):1034–42. doi: 10.1124/jpet.104.077669.
creator http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_edec72b85084dd5c98a680a11564fe01
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_469092e6786e004a4383ccac56f9fe63
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_5ce78efcba66359f4b06e963120b5eff
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_10765d12e8ada94db85daac929783ca0
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_4f7eafddbcd47a934594655c4fede08b
http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-2923-5714
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_8b0afac92ce59f81b8d71923172ccb9b
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_eb3e0c0132996cc943f4b41453a2a4ab
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_67b0e29524b1f2712cfe04e3b6fb654b
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_0f47853e63f49dbf08aa8f81609c8918
date 2004-11-04-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier https://doi.org/10.1124/jpet.104.077669
https://pubmed.ncbi.nlm.nih.gov/15528450
isPartOf https://portal.issn.org/resource/ISSN/0022-3565
http://rdf.ncbi.nlm.nih.gov/pubchem/journal/5173
https://portal.issn.org/resource/ISSN/1521-0103
language English
source https://www.crossref.org/
https://pubmed.ncbi.nlm.nih.gov/
title Dual, Hyperalgesic, and Analgesic Effects of the High-Efficacy 5-Hydroxytryptamine 1A (5-HT1A) Agonist F 13640 [(3-Chloro-4-fluoro-phenyl)-[4-fluoro-4-{[(5-methyl-pyridin-2-ylmethyl)-amino]-methyl}piperidin-1-yl]methanone, Fumaric Acid Salt]: Relationship with 5-HT1A Receptor Occupancy and Kinetic Parameters
discusses http://id.nlm.nih.gov/mesh/M0026371
http://id.nlm.nih.gov/mesh/M0449474
http://id.nlm.nih.gov/mesh/M0018233
http://id.nlm.nih.gov/mesh/M0001067
http://id.nlm.nih.gov/mesh/M0016885
http://id.nlm.nih.gov/mesh/M0026368
hasPrimarySubjectTerm http://id.nlm.nih.gov/mesh/D058825
http://id.nlm.nih.gov/mesh/D006930Q000139
http://id.nlm.nih.gov/mesh/D011725Q000494
http://id.nlm.nih.gov/mesh/D017366Q000494
http://id.nlm.nih.gov/mesh/D010880Q000494
http://id.nlm.nih.gov/mesh/D000700Q000494
hasSubjectTerm http://id.nlm.nih.gov/mesh/D017551
http://id.nlm.nih.gov/mesh/D010880Q000097
http://id.nlm.nih.gov/mesh/D008297
http://id.nlm.nih.gov/mesh/D004305
http://id.nlm.nih.gov/mesh/D051381
http://id.nlm.nih.gov/mesh/D011725Q000097
http://id.nlm.nih.gov/mesh/D017207
http://id.nlm.nih.gov/mesh/D000818
discussesAsDerivedByTextMining http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_5ea68a9c7904628fa121983472b0126c
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5202
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9916
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9865384
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1220
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID64747
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8756
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8060
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID712

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129095671

Total number of triples: 59.